AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PERCHERON FPO

0.008

0.000

Volume:2.05M

Turnover:14.41K

Market Cap:8.70M

PE:-0.55

High:0.008

Open:0.007

Low:0.007

Close:0.008

52wk High:0.015

52wk Low:0.006

Shares:1.09B

Float Shares:816.63M

Volume Ratio:2.21

T/O Rate:0.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.015

EPS(LYR):-0.015

ROE:-154.10%

ROA:-69.10%

PB:0.87

PE(LYR):-0.55

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Percheron Therapeutics Appoints Chief Medical Officer, Chief Technology Officer

MT Newswires Live

Change of Director's Interest Notice - Dr James Garner-PER.AX

Ceasing to be a substantial holder from PVL,PVL-PER.AX

Percheron Therapeutics Limited Corporate Presentation-PER.AX

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PER.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PER.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PER.AU\",,,,,undefined,":{"symbol":"PER.AU","market":"AU","secType":"STK","nameCN":"PERCHERON FPO","latestPrice":0.008,"timestamp":1770354720000,"preClose":0.008,"halted":0,"volume":2051581,"delay":0,"changeRate":0,"nameEN":"PERCHERON FPO","floatShares":816628906,"shares":1087437633,"eps":-0.014599,"marketStatus":"Market Closed","change":0,"latestTime":"02-06 16:12:00 AEDT","open":0.007,"high":0.008,"low":0.007,"amount":14410,"amplitude":0.125,"askPrice":0.008,"askSize":3493026,"bidPrice":0.007,"bidSize":4364014,"shortable":3,"etf":0,"ttmEps":-0.014599,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.008,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":2.2149628627403417,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PER.AU\",,,,,undefined,":{"symbol":"PER.AU","floatShares":816628906,"roa":"-69.10%","roe":"-154.10%","lyrEps":-0.01457,"volumeRatio":2.2149628627403417,"shares":1087437633,"dividePrice":0,"high":0.008,"amplitude":0.125,"preClose":0.008,"low":0.007,"week52Low":0.006,"pbRate":"0.87","psRate":"4.83","week52High":0.015,"institutionHeld":0,"latestPrice":0.008,"committee":0.110854,"eps":-0.014599,"divideRate":0,"volume":2051581,"delay":0,"ttmEps":-0.014599,"open":0.007,"prevYearClose":0.009,"prevWeekClose":0.009,"prevMonthClose":0.009,"prevQuarterClose":0.009,"fiveDayClose":0.009,"twentyDayClose":0.009,"sixtyDayClose":0.007},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PER.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PER.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PER.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2569797764","title":"Percheron Therapeutics Appoints Chief Medical Officer, Chief Technology Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2569797764","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569797764?lang=en_us&edition=fundamental","pubTime":"2025-09-23 14:55","pubTimestamp":1758610538,"startTime":"0","endTime":"0","summary":"Percheron Therapeutics  appointed Eugene Kennedy as chief medical officer and Valentina Dubljevic as chief technology officer, according to a Tuesday filing with the Australian bourse.These appointments align with the company's upcoming phase two trial of its lead program, HMBD-002, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","XAO.AU","XJO.AU","BK4007","PER.AU","BK4539","BK7096","BK4139","LENZ"],"gpt_icon":0},{"id":"2548704509","title":"Change of Director's Interest Notice - Dr James Garner-PER.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2548704509","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548704509?lang=en_us&edition=fundamental","pubTime":"2025-07-01 06:39","pubTimestamp":1751323156,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nASX78Pzw6","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nASX7LY9Zh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","PER.AU"],"gpt_icon":0},{"id":"2547031347","title":"Ceasing to be a substantial holder from PVL,PVL-PER.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2547031347","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547031347?lang=en_us&edition=fundamental","pubTime":"2025-06-30 09:05","pubTimestamp":1751245535,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nASX8f94YT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nASX6VhLv2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PER.AU","BK7096","BK7062","PVL.AU"],"gpt_icon":0},{"id":"2546752141","title":"Percheron Therapeutics Limited Corporate Presentation-PER.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2546752141","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546752141?lang=en_us&edition=fundamental","pubTime":"2025-06-27 06:25","pubTimestamp":1750976727,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250626:nASX2wrlzd","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nASX1HSKpC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PER.AU","BK7096"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PER.AU\",params:#limit:6,delay:true,,,undefined,":[]}}